Hercules Capital Other Long-Term Assets 2010-2024 | HTGC
Hercules Capital other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Hercules Capital Annual Other Long-Term Assets (Millions of US $) |
2023 |
$15 |
2022 |
$2 |
2021 |
$5 |
2020 |
$4 |
2019 |
$1 |
2018 |
$2 |
2017 |
$5 |
2016 |
$7 |
2015 |
$10 |
2014 |
$29 |
2013 |
$28 |
2012 |
$25 |
2011 |
$24 |
2010 |
$8 |
2009 |
$6 |
Hercules Capital Quarterly Other Long-Term Assets (Millions of US $) |
2024-09-30 |
$3 |
2024-06-30 |
$15 |
2024-03-31 |
$10 |
2023-12-31 |
$15 |
2023-09-30 |
$1 |
2023-06-30 |
$2 |
2023-03-31 |
$7 |
2022-12-31 |
$2 |
2022-09-30 |
$2 |
2022-06-30 |
$4 |
2022-03-31 |
$11 |
2021-12-31 |
$5 |
2021-09-30 |
$5 |
2021-06-30 |
$6 |
2021-03-31 |
$3 |
2020-12-31 |
$4 |
2020-09-30 |
$6 |
2020-06-30 |
$6 |
2020-03-31 |
$8 |
2019-12-31 |
$1 |
2019-09-30 |
$2 |
2019-06-30 |
$4 |
2019-03-31 |
$4 |
2018-12-31 |
$2 |
2018-09-30 |
$1 |
2018-06-30 |
$1 |
2018-03-31 |
$3 |
2017-12-31 |
$5 |
2017-09-30 |
$7 |
2017-06-30 |
$5 |
2017-03-31 |
$7 |
2016-12-31 |
$7 |
2016-09-30 |
$10 |
2016-06-30 |
$20 |
2016-03-31 |
$12 |
2015-12-31 |
$10 |
2015-09-30 |
$20 |
2015-06-30 |
$21 |
2015-03-31 |
$23 |
2014-12-31 |
$29 |
2014-09-30 |
$31 |
2014-06-30 |
$30 |
2014-03-31 |
$31 |
2013-12-31 |
$28 |
2013-09-30 |
$25 |
2013-06-30 |
$24 |
2013-03-31 |
$26 |
2012-12-31 |
$25 |
2012-09-30 |
$20 |
2012-06-30 |
$16 |
2012-03-31 |
$15 |
2011-12-31 |
$24 |
2011-09-30 |
$11 |
2011-06-30 |
$14 |
2011-03-31 |
$11 |
2010-12-31 |
$8 |
2010-09-30 |
$7 |
2010-06-30 |
$7 |
2010-03-31 |
$7 |
2009-12-31 |
$6 |
2009-09-30 |
$6 |
2009-06-30 |
$7 |
2009-03-31 |
$7 |
Sector |
Industry |
Market Cap |
Revenue |
Finance |
Finance - SBIC & Commercial |
$3.195B |
$0.461B |
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|